Medical Journals

Eadock: Docking of Small Molecules into Protein Active Sites with a Multiobjective Evolutionary Optimization.

Authors:
  • Grosdidier Aurélien
  • Zoete Vincent
  • Michielin Olivier

From: Swiss Institute of Bioinformatics, Molecular Modeling Group, Quartier Sorges, Bâtiment Génopode, CH-1015 Lausanne, Switzerland.

Proteins

  • Publish Date: Jun 2007
  • ISSN: 1097-0134
  • Volume: 67
  • Issue: 4
  • Pages: 1010-25
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Grosdidier Aurélien, Zoete Vincent, Michielin Olivier, et al. Eadock: Docking of Small Molecules into Protein Active Sites with a Multiobjective Evolutionary Optimization.. Proteins Jun 2007;67:1010-25

Abstract

In recent years, protein-ligand docking has become a powerful tool for drug development. Although several approaches suitable for high throughput screening are available, there is a need for methods able to identify binding modes with high accuracy. This accuracy is essential to reliably compute the binding free energy of the ligand. Such methods are needed when the binding mode of lead compounds is not determined experimentally but is needed for structure-based lead optimization. We present here a new docking software, called EADock, that aims at this goal. It uses an hybrid evolutionary algorithm with two fitness functions, in combination with a sophisticated management of the diversity. EADock is interfaced with the CHARMM package for energy calculations and coordinate handling. A validation was carried out on 37 crystallized protein-ligand complexes featuring 11 different proteins. The search space was defined as a sphere of 15 A around the center of mass of the ligand position in the crystal structure, and on the contrary to other benchmarks, our algorithm was fed with optimized ligand positions up to 10 A root mean square deviation (RMSD) from the crystal structure, excluding the latter. This validation illustrates the efficiency of our sampling strategy, as correct binding modes, defined by a RMSD to the crystal structure lower than 2 A, were identified and ranked first for 68% of the complexes. The success rate increases to 78% when considering the five best ranked clusters, and 92% when all clusters present in the last generation are taken into account. Most failures could be explained by the presence of crystal contacts in the experimental structure. Finally, the ability of EADock to accurately predict binding modes on a real application was illustrated by the successful docking of the RGD cyclic pentapeptide on the alphaVbeta3 integrin, starting far away from the binding pocket.

Mesh Headings (Keywords): Algorithms, Binding Sites, Computer Simulation, Crystallography, X-Ray, Electrostatics, Evolution, Molecular, Ligands, Models, Molecular, Probability, Protein Binding, Protein Structure, Tertiary, Proteins


Check for Full Text / PubMed Unique Identifier (PMID): 17380512


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.